Swen Hesse Selected Research

3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrile

1/2021	Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension.
12/2020	Higher HbA1c levels associate with lower hippocampal serotonin transporter availability in non-diabetic adults with obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Swen Hesse Research Topics

Disease

12	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2011
12	Obesity 12/2020 - 01/2013
7	Cognitive Dysfunction 01/2022 - 03/2011
7	Dementia (Dementias) 01/2022 - 06/2016
6	Parkinson Disease (Parkinson's Disease) 02/2021 - 05/2004
5	Weight Loss (Weight Reduction) 11/2021 - 05/2015
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2016
4	Body Weight (Weight, Body) 01/2018 - 05/2015
4	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 06/2011 - 08/2004
3	Disease Progression 01/2022 - 01/2018
3	Hyperthyroidism 01/2021 - 09/2015
3	Multiple Sclerosis 01/2021 - 05/2014
2	Morbid Obesity 11/2021 - 01/2017
2	Fatigue 01/2021 - 01/2020
2	Pulmonary Hypertension 01/2021 - 06/2016
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2019 - 02/2009
2	Movement Disorders (Movement Disorder) 07/2019 - 08/2008
2	Hyperphagia (Overeating) 06/2017 - 01/2013
2	Depressive Disorder (Melancholia) 09/2015 - 08/2009
1	Tremor (Tremors) 02/2021
1	Huntington Disease (Huntington's Disease) 01/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Atherosclerosis 07/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2017
1	Atrophy 11/2016
1	Parkinsonian Disorders (Parkinsonism) 07/2016
1	Lung Diseases (Lung Disease) 06/2016
1	Tobacco Use Disorder (Nicotine Dependence) 09/2015
1	Hypothyroidism 09/2015
1	Overweight 01/2013
1	Mood Disorders (Mood Disorder) 05/2011

Drug/Important Bio-Agent (IBA)

8	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2021 - 08/2004
8	Serotonin (5 Hydroxytryptamine)IBA 12/2020 - 05/2004
7	Biomarkers (Surrogate Marker)IBA 07/2019 - 09/2011
7	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2018 - 09/2011
6	N-acetyltalosaminuronic acid (NAT)IBA 11/2021 - 06/2017
5	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2021 - 10/2005
5	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 08/2009
5	Amyloid (Amyloid Fibrils)IBA 01/2021 - 09/2011
5	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2021 - 01/2018
4	2beta- carbomethoxy- 3beta- (4- iodophenyl)tropane (Iometopane)IBA 01/2006 - 08/2002
3	Cholinergic Agents (Cholinergics)IBA 01/2022 - 03/2011
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2021 - 06/2017
3	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 02/2021 - 02/2009
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2018 - 08/2004
2	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 01/2021 - 12/2020
2	Biological ProductsIBA 07/2019 - 10/2016
2	Neurotransmitter Agents (Neurotransmitter)IBA 06/2017 - 01/2013
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2016 - 06/2016
2	Glucose (Dextrose)FDA LinkGeneric 06/2016 - 05/2011
2	3- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA 08/2008 - 02/2003
1	3- (1,4- diazabicyclo(3.2.2)nonan- 4- yl)- 6- fluorodibenzo(b,d)thiophene 5,5-dioxideIBA 01/2022
1	EnzymesIBA 01/2022
1	Cholinergic ReceptorsIBA 01/2022
1	proenkephalinIBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	fluoronorchloroepibatidineIBA 01/2021
1	alpha-2-HS-GlycoproteinIBA 01/2021
1	fibroblast growth factor 21IBA 01/2021
1	Fatty Acid-Binding ProteinsIBA 01/2021
1	pridopidineIBA 01/2021
1	1'- benzyl- 3- (2- fluoroethyl)- 3H- spiro((2)benzofuran- 1,4'- piperidine)IBA 01/2021
1	fallyprideIBA 01/2021
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2021
1	NeuregulinsIBA 01/2021
1	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2021
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2021
1	LigandsIBA 01/2021
1	Investigational DrugsIBA 01/2021
1	NeurotensinIBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2020
1	PrionsIBA 07/2019
1	Cholinesterases (Cholinesterase)IBA 01/2018
1	Peptides (Polypeptides)IBA 07/2017
1	Amyloid beta-PeptidesIBA 07/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2017
1	Arginine Vasopressin (Argipressin)IBA 01/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 12/2016
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2016
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 08/2016
1	carfentanil (carfentanyl)IBA 01/2016
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 01/2016
1	Opioid Receptors (Opioid Receptor)IBA 01/2016
1	IodineIBA 09/2015
1	Drinking WaterIBA 09/2015
1	Thyroxine (Levothyroxine)FDA LinkGeneric 09/2015
1	Blood Proteins (Serum Proteins)IBA 07/2014
1	LipidsIBA 04/2013
1	nicotinic receptor alpha4beta2IBA 08/2009
1	Citalopram FDA LinkGeneric 01/2006

Therapy/Procedure

3	Bariatric Surgery 01/2017 - 05/2015
2	Therapeutics 01/2022 - 01/2018
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 11/2021 - 05/2015
2	Deep Brain Stimulation 02/2021 - 07/2008
1	Immunotherapy 01/2020